衰老关键蛋白1(FBLN1)单克隆抗体
Monoclonal Antibody to Fibulin 1 (FBLN1)
- 编号MAC472Mu22
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源单抗制备
- 宿主小鼠
- 效价(克隆号)C11
- Ig亚型 IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原-
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度1mg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载英文说明书 中文说明书
- 规格20µl100µl200µl1ml10ml
- 价格¥ 783¥ 1827¥ 2610¥ 6525¥ 26100
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
AF488 staining on IF;
Sample: Hepa1-6 cell
Primary Ab: 20µg/ml Mouse Anti-Mouse FBLN1 Antibody
Second Ab: 2μg/ml AF488-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu11)
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对FBLN1的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别FBLN1。
用法
Western blotting: 0.2-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPC472Mu01 | 衰老关键蛋白1(FBLN1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC472Mu01 | 衰老关键蛋白1(FBLN1)多克隆抗体 | WB; IHC; ICC; IP. |
| LAC472Mu71 | 衰老关键蛋白1(FBLN1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAC472Mu22 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC; ICC; IP. |
| MAC472Mu21 | 衰老关键蛋白1(FBLN1)单克隆抗体 | WB; IHC; ICC; IP. |
| LAC472Mu72 | 衰老关键蛋白1(FBLN1)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEC472Mu | 衰老关键蛋白1(FBLN1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC472Mu | 衰老关键蛋白1(FBLN1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| PSC472Mu01 | 衰老关键蛋白1(FBLN1)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSC472Mu01 | 衰老关键蛋白1(FBLN1)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
| 杂志 | 参考文献 |
| Clin Exp Metastasis. | Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734] |
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509] |
| PROTEOMICS - Clinical Applications | Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients.[pubmed:26680509] |
| ENVIRONMENTAL RESEARCH | Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421] |